Findings presented at 50th Annual Meeting of ASCO show aromatase inhibitor effective for premenopausal women when combined with ovarian function suppression.
Sandra Kear, OncLive
Advertisement
Articles by Sandra Kear, OncLive
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Orforglipron Reduces Body Weight Up to 14% in Women at Every Stage of Menopause
2
Staging the Heart: NLA and EAS Reveal a New Era of Precision Lipidology and Imaging
3
Managing Grade 1 CRS in Patients With Follicular Lymphoma on Bispecific Antibodies: Home vs Health Care Facility Referred
4
New Evidence Positions Finerenone as Foundational Therapy Across the CKD Spectrum
5